triazoles has been researched along with Mucositis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Aerts, R; Blijlevens, NMA; Brüggemann, RJM; Burger, D; Colbers, A; Jansen, AME; Maertens, JA; Muilwijk, EW; Ter Heine, R; van der Velden, WJFM; Verweij, PE | 1 |
| Baker, KK; Chin, A; Fredricks, DN; Hoofnagle, AN; Jain, R; Pergam, SA | 1 |
| Abzug, MJ; Curtis, D; Hurst, AL; Strommen, A | 1 |
| Annaert, P; Augustijns, P; Hoenigl, M; Lagrou, K; Maertens, J; Mols, R; Peersman, N; Prattes, J; Schoemans, H; Spriet, I; Theunissen, K; Vanstraelen, K; Vermeersch, P | 1 |
| Desai, AV; Engelhardt, M; Hope, WW; Kovanda, LL; Lademacher, C; Lu, Q; Maertens, J; Marty, FM | 1 |
| Bougnoux, ME; Buzyn, A; Elie, C; Jullien, V; Lanternier, F; Lebeaux, D; Lecuit, M; Lortholary, O; Suarez, F; Viard, JP | 1 |
| Anaissie, EJ; Dong, L; Gubbins, PO; Krishna, G; Martinho, M; Penzak, SR; Sansone-Parsons, A | 1 |
| Kontoyiannis, DP; Lewis, RE | 1 |
2 trial(s) available for triazoles and Mucositis
| Article | Year |
|---|---|
Posaconazole bioavailability of the solid oral tablet is reduced during severe intestinal mucositis.
Topics: Administration, Oral; Antifungal Agents; Biological Availability; Humans; Mucositis; Tablets; Triazoles | 2022 |
Impact of Mucositis on Absorption and Systemic Drug Exposure of Isavuconazole.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Biological Availability; Female; Humans; Invasive Fungal Infections; Male; Middle Aged; Mucormycosis; Mucositis; Nitriles; Pyridines; Treatment Outcome; Triazoles; Young Adult | 2017 |
6 other study(ies) available for triazoles and Mucositis
| Article | Year |
|---|---|
Evaluation of Posaconazole Serum Concentrations from Delayed-Release Tablets in Patients at High Risk for Fungal Infections.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Female; Fusarium; Humans; Invasive Fungal Infections; Male; Middle Aged; Mucorales; Mucositis; Retrospective Studies; Triazoles | 2017 |
Use of Intravenous Posaconazole in Hematopoietic Stem Cell Transplant Patients.
Topics: Administration, Intravenous; Allografts; Child; Gastrointestinal Diseases; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Mucositis; Triazoles | 2018 |
Posaconazole plasma exposure correlated to intestinal mucositis in allogeneic stem cell transplant patients.
Topics: Administration, Oral; Adult; Antifungal Agents; Citrulline; Female; Hematopoietic Stem Cell Transplantation; Humans; Intestinal Mucosa; Male; Middle Aged; Mucositis; Mycoses; Suspensions; Tablets; Triazoles | 2016 |
Therapeutic drug monitoring of posaconazole: a monocentric study with 54 adults.
Topics: Adult; Antifungal Agents; Diarrhea; Drug Monitoring; Female; Humans; Male; Middle Aged; Mucositis; Mycoses; Retrospective Studies; Triazoles | 2009 |
Pharmacokinetics and safety of oral posaconazole in neutropenic stem cell transplant recipients.
Topics: Antifungal Agents; Area Under Curve; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Humans; Male; Middle Aged; Mucositis; Neutropenia; Severity of Illness Index; Stem Cell Transplantation; Triazoles | 2006 |
Posaconazole prophylaxis in hematologic cancer.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Humans; Mucositis; Mycoses; Opportunistic Infections; Oxidoreductases; Point Mutation; Pyrimidines; Sterol 14-Demethylase; Triazoles; Voriconazole | 2007 |